United Therapeutics Corporation
Biotechnology company reports second quarter 2004 financial results
Published in Physician Law Weekly, September 1st, 2004
Revenues grew to $18.3 million in the second quarter of 2004, as compared to $14.0 million in the second quarter of 2003. Gross margins from sales were $16.3 million or 89% in the second quarter of 2004, as compared to $12.0 million or 86% in the second quarter of 2003. This increase in revenues and the improvement in gross margins resulted primarily from expanded sales of Remodulin.
The company earned its first ever quarterly net income of $4.1 million or $0.19 per basic share in the second quarter of 2004, as compared to a net loss of $2.4...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2004-09-01)
More Articles from Physician Law Weekly
- Abbott Laboratories
Government decides not to intervene and force down AIDS drug price - Archemix Corp.
Biopharmaceutical company names vice president of business development - Best Practices, LLC
Drug companies approach brand security issue head on, study shows - Business Update
Altria sees $25 million gain from accounting rule - Ciphergen Biosystems Inc.
Report published on biomarkers for early diagnosis of intra-amniotic infection - CytRx Corp.
RNAi company names Benjamin S. Levin general counsel - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
